FDA Inspection
Department of Defense - NavyDepartment of Defense - Navy – FDA Inspection, Sep 9, 2013
Record Details
This FDA Inspection record concerns Department of Defense - Navy, with an inspection on September 9, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Department of Defense - Navy
- Inspection Date
- September 9, 2013
- Product Type
- Biologics
View Company Profile
ID · cbf07b13-9c45-40ba-bf8a-533130b53480
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 847540
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.171Biological product deviation report
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Department of Defense - Navy
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 3, 2024 | VAI | Baltimore District Office | Blood and Blood Products |
| March 11, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| September 20, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 6, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 2, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Department of Defense - Navy
- FDA Inspection 1250935 - 2024-10-03
- FDA Inspection 1167020 - 2022-03-11
- FDA Inspection 1068540 - 2018-09-20
- FDA Inspection 937758 - 2015-08-06
- FDA Inspection 722889 - 2011-05-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.